When President Trump talks about efforts to deliver the coronavirus vaccine to millions of Americans eager to return to their normal lives, he often says he is “counting on the Continue Reading
Days after grabbing headlines with its COVID-19 “vaccine for the world”, AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting Continue Reading
On November 9 US pharmaceutical giant Pfizer and German biotechnology company BioNTech announced that a jointly developed vaccine candidate was effective at preventing more than 90% of test subjects from Continue Reading
South Korea will close down up to 16 coal-fired power plants for three months from December, out of its 60 coal power plants in total, to help reduce air pollution, Continue Reading
The explosive growth seen in China’s grain demand this year has not been caused by just a temporary supply shortage but signals a structural change in domestic consumption levels, US Continue Reading
What started as a Midwestern surge has grown into coast-to-coast disaster. Over the last two months, rural counties and midsize cities in the Great Plains and Upper Midwest have been Continue Reading
The announcement this week that a cheap, easy-to-make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. “Get yourself a vaccaccino,” a British tabloid celebrated Continue Reading
The COVID-19-causing coronavirus is mutating as it spreads around the world in the pandemic, but none of the mutations currently documented appears to be making it able to spread more Continue Reading
Disquiet is growing over the way that Oxford university and AstraZeneca have handled the early readout from trials of their coronavirus vaccine, which much of the developing world may rely Continue Reading
Andrew Testa for The New York Times make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. “Get yourself a vaccaccino,” a British tabloid celebrated Continue Reading
